Literature DB >> 5043134

Antibody activities of IgM and IgG fractions from rabbit anti-Erysipelothrix rhusiopathiae sera.

Y Yokomizo, Y Isayama.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 5043134

Source DB:  PubMed          Journal:  Res Vet Sci        ISSN: 0034-5288            Impact factor:   2.534


× No keyword cloud information.
  6 in total

1.  Erysipelothrix rhusiopathiae YS-1 as a live vaccine vehicle for heterologous protein expression and intranasal immunization of pigs.

Authors:  Yoshihiro Shimoji; Eiji Oishi; Takashi Kitajima; Yoshihiro Muneta; Shinya Shimizu; Yasuyuki Mori
Journal:  Infect Immun       Date:  2002-01       Impact factor: 3.441

2.  Intracellular survival and replication of Erysipelothrix rhusiopathiae within murine macrophages: failure of induction of the oxidative burst of macrophages.

Authors:  Y Shimoji; Y Yokomizo; Y Mori
Journal:  Infect Immun       Date:  1996-05       Impact factor: 3.441

3.  Immunological characterization of a protective antigen of Erysipelothrix rhusiopathiae: identification of the region responsible for protective immunity.

Authors:  Y Shimoji; Y Mori; V A Fischetti
Journal:  Infect Immun       Date:  1999-04       Impact factor: 3.441

4.  Genome-Wide Identification of Virulence Genes in Erysipelothrix rhusiopathiae: Use of a Mutant Deficient in a tagF Homolog as a Safe Oral Vaccine against Swine Erysipelas.

Authors:  Yoshihiro Shimoji; Yohsuke Ogawa; Manae Tsukio; Kazumasa Shiraiwa; Sayaka Nishikawa; Masahiro Eguchi
Journal:  Infect Immun       Date:  2019-11-18       Impact factor: 3.441

5.  Construction and vaccine potential of acapsular mutants of Erysipelothrix rhusiopathiae: use of excision of Tn916 to inactivate a target gene.

Authors:  Y Shimoji; Y Mori; T Sekizaki; T Shibahara; Y Yokomizo
Journal:  Infect Immun       Date:  1998-07       Impact factor: 3.441

6.  Presence of a capsule in Erysipelothrix rhusiopathiae and its relationship to virulence for mice.

Authors:  Y Shimoji; Y Yokomizo; T Sekizaki; Y Mori; M Kubo
Journal:  Infect Immun       Date:  1994-07       Impact factor: 3.441

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.